Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
BARDA Conducting Market Research on Ebola Medical Countermeasures Contracts + Grants February 23, 2017 …
Emergent BioSolutions to Develop Viral Hemorrhagic Fever Therapeutics Under BARDA Contract Featured News February 16, 2017 …
New Method Enables Rapid testing of Nanoparticles for Countermeasure Delivery Medical Countermeasures February 7, 2017 …
RFP – Nonhuman Primate Virology Laboratory for AIDS Vaccine Research Contracts + Grants February 6, 2017 …
Elusys Delivers Anthrax Countermeasure Order, Gains Funding for Lyophilization Effort Contracts + Grants February 2, 2017 …
NIAID-Backed Phase 1b Study to Evaluate Broad-Spectrum Antiviral for Dengue Featured News February 1, 2017 …
International Partners Work to Develop Crimean–Congo Hemorrhagic Fever Vaccine Featured News January 24, 2017 …
New Coalition for Epidemic Preparedness Sets Sights on MERS-CoV, Lassa and Nipah Medical Countermeasures January 19, 2017 …
DTRA Leveraging Approved Drugs to Expand Biodefense AMR Countermeasure Arsenal Antimicrobial Resistance January 17, 2017 …
Military Recruiting Volunteers for Human Trials of Malaria Vaccines Defense + Military January 10, 2017 …
CDC Program Helps Democratic Republic of the Congo Combat Monkeypox Biosurveillance January 10, 2017 …
PaxVax Announces Partnership with NIH and DOD for Chikungunya Vaccine Program Defense + Military January 10, 2017 …
RFI – Development of Animal Models for Antibacterial Drug Development Antimicrobial Resistance January 5, 2017 …
CUBRC, EpiVax Awarded DTRA Contract for Burkholderia Vaccine Antigen Design Contracts + Grants January 3, 2017 …
